SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
International application of the Incidence Rate/Window Period model
5 references·16 citing·30 second hop
International application of the Incidence Rate/Window Period model (2002)International application of the Incidenc…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Trends in Incidence and Preva…The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Estimated Risk of Transmissio…Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Nucleic acid testing for bloo…The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): Twenty Years of Research to Advance Blood Product Safety and Availability (2012)The National Heart, Lung, and…The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)The Risk of HIV, HBV, HCV and…Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Residual risk of transfusion‐…Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa (2006)Prevalence of HIV-1 in Blood …Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Assessing the impact of HBV N…Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Residual risk of transfusion‐…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Multicenter performance evalu…Marcadores sorológicos das hepatites B e C em doadores de sangue do Hemocentro de Ribeirão Preto, SP (2005)Marcadores sorológicos das he…Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Human immunodeficiency virus,…Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral (2004)Risque résiduel de transmissi…Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Cost‐effectiveness of nucleic…Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Incidence and estimated rates…Effect of a National Disaster on Blood Supply and Safety (2003)Effect of a National Disaster…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Current risk for transfusion transmitted infections (2007)Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (2007)Informative Dorfman Screening (2011)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Why do they give the gift of life? A review of research on blood donors since 1977 (1990)Motivations to donate blood: demographic comparisons (2002)How Can We Improve Retention of the First-Time Donor? A Systematic Review of the Current Evidence (2016)Simulation-optimization model for production planning in the blood supply chain (2016)Liability of foreignness, natural disasters, and corporate philanthropy (2017)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Methods for the economic evaluation of health care programmes (1987)Perception of Risk (1987)Cost-Effectiveness in Health and Medicine (1996)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Cost-Effectiveness Analysis: What It Really Means for Transfusion Medicine Decision Making (2008)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Safety of the Blood Supply in Latin America (2005)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Prevention of transfusion-transmitted infections (2019)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 1995Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States346 cited
  • 2000Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996287 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited

Cited by

  • 2004Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States136 cited
  • 2003Effect of a National Disaster on Blood Supply and Safety132 cited
  • 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
  • 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2005Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing95 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

94 cited
  • 2007Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 200470 cited
  • 2004Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral66 cited
  • 2006Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa63 cited
  • 2007The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia60 cited
  • 2005Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy57 cited
  • 2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
  • 2005Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations56 cited
  • 2012The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): Twenty Years of Research to Advance Blood Product Safety and Availability50 cited
  • 2005Marcadores sorológicos das hepatites B e C em doadores de sangue do Hemocentro de Ribeirão Preto, SP39 cited